Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings crawled date : 2022 - 03 - 01 save search
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 23:00) - biospace.com/
CARA | $0.6816 -1.22% -1.23% 350K
|
Health Technology
|
| O: -0.39%
H: 2.13%
C: -2.61%
financial results therapeutics report results
Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
SNDX | $20.82 1.61% 1.59% 850K
|
Health Technology
|
| O: -0.64%
H: 4.26%
C: 3.68%
als financial results report results
REGENXBIO Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Operational Highlights
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.9%
H: 0.0%
C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: -0.42%
H: 2.66%
C: 0.49%
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: 0.56%
H: 0.22%
C: -6.92%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: 0.34%
H: 2.79%
C: 0.57%
financial results report results
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Pipeline and Business Progress
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: -0.17%
H: 1.27%
C: 0.17%
als financial results report results
Cerevel Therapeutics Provides Update on Pipeline Progress along with Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
CERE | $42.15 0.02% 0.02% 810K
|
Finance
|
| O: -1.25%
H: 13.96%
C: 8.53%
financial results therapeutics results
Seres Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
financial results therapeutics report results
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
AXSM | $67.91 3.33% 3.22% 890K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: 0.0%
financial results therapeutics report results
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2021
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
NOVT | News | $149.28 -0.49% -0.5% 160K
|
Electronic Technology
|
| O: -1.19%
H: 1.39%
C: -3.5%
financial results ces results
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
BCYC | $23.41 -4.41% -4.61% 550K
|
Health Technology
|
| O: -2.74%
H: 6.28%
C: 2.38%
financial results therapeutics report results
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 10, 2022
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: -0.71%
H: 2.26%
C: -2.14%
financial results therapeutics cel report results
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
ITCI 1 d | $72.29 0.4% 0.4% 2.2M
|
Health Technology
|
| O: -0.87%
H: 7.05%
C: 2.73%
financial results cel report results therapy
Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 3.13%
H: 0.0%
C: 0.0%
financial results ces therapeutics report results
Precigen Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
PGEN | $1.33 0.76% 0.75% 1M
|
Health Technology
|
| O: -4.89%
H: 4.21%
C: 0.93%
financial results report results
Minerva Neurosciences Reports Fourth Quarter 2021 Financial Results and Business Updates
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
NERV | $2.5 1.2% 11K
|
Health Technology
|
| O: -0.79%
H: 5.62%
C: -1.41%
financial results report results
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results Conference call to be held today, Tuesday, March 1, 2022, at 8:30 AM ET
Published: 2022-03-01 (Crawled : 14:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.91%
H: 5.9%
C: 2.9%
day financial results conference therapeutics report results oda
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -15.54%
H: 29.6%
C: 27.2%
financial results report results
Forma Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
FMTX | $20.01 -0.15%
|
Health Technology
|
| O: -2.24%
H: 7.47%
C: -1.59%
financial results therapeutics report results
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
QTRX | $15.84 0.32% 0.32% 360K
|
Health Technology
|
| O: 3.95%
H: 6.39%
C: -6.56%
corporation results
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Published: 2022-03-01 (Crawled : 12:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.91%
H: 3.38%
C: -2.7%
als financial results report results
Amarin Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 12:00) - biospace.com/
AMRN | News | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: 3.72%
H: 1.19%
C: -4.78%
financial results report results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.